Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 223

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 223
---
 (“Norton Capital”), and may be deemed to be beneficially owned by Robert Norton, as the Manager of Norton Capital. Robert Norton disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (15) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (16) | The reported securities are held directly by RAJK Family Limited Partners LLC (“RAJK”), and may be deemed to be beneficially owned by Amita Patel, as the Manager of RAJK. Amita Patel disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein. |

| (17) | Excludes, for beneficial ownership purposes, 150,944 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025 |

| (18) | The reported securities are held directly by Tapper Ventures Inc. and may be deemed to be beneficially owned by Thomas Pepin, who has sole voting and investment power. Thomas Pepin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (19) | Excludes, for beneficial ownership purposes 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (20) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (21) | Excludes, for beneficial ownership purposes, 226,416 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025 |

144

| (22) | The reported securities are held directly by KMS Health LLP (“KMS Health”) and may be deemed to be beneficially owned by Zacharias Kalarickal, Manager of KMS Health. Zacharias Kalarickal disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. |

| (23) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 23, 2025. |

| (24) | Excludes, for beneficial ownership purposes, 28,304 warrants to purchase common stock